Unlocking the Potential for Myotropic AAV Capsids
Time: 11:15 am
day: Day Two
Details:
- Using RGD motif to improve to specificity of the AAVs to muscle cells
- Exploring specific peptide insertions to de-target the liver and reduce toxicity
- Harnessing antibody technologies to support retargeting AAV to muscle cells
